Enterprise Value
58.15M
Cash
14.87M
Avg Qtr Burn
-1.829M
Short % of Float
3.14%
Insider Ownership
2.89%
Institutional Own.
6.62%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Triferic® AVNU (ferric pyrophosphate citrate) Details Chronic kidney disease, Psoriasis, Kidney disease | Approved Quarterly sales | |
Triferic (ferric pyrophosphate citrate) Details Anemia (hemodialysis dependent chronic kidney disease) | Approved Quarterly sales |